Загрузка...
Targeting Ras signaling in AML: RALB is a small GTPase with big potential
Acute myeloid leukemia (AML) is a devastating malignancy for which novel treatment approaches are desperately needed. Ras signaling is an attractive therapeutic target for AML because a large proportion of AMLs have mutations in NRAS, KRAS, or genes that activate Ras signaling, and key Ras effectors...
Сохранить в:
| Опубликовано в: : | Small GTPases |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6959283/ https://ncbi.nlm.nih.gov/pubmed/28682649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21541248.2017.1339765 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|